Showing results (51-60 of 210) with videos related to
Sort By:
Pageof 21
Nature Reviews. Neuroscience|September 21, 2011
Diencephalic and brainstem mechanisms in migraineSimon Akerman, Philip R Holland, Peter J GoadsbyThe Journal of Headache and Pain|March 15, 2018
PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchymaJames A Waschek, Serapio M Baca, Simon AkermanBritish Journal of Pharmacology|July 9, 2004
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the catRobin James Storer, Simon Akerman, Peter J GoadsbyNeurobiology of Pain (Cambridge, Mass.)|March 28, 2023
Nitroglycerin as a model of migraine: Clinical and preclinical reviewPaula Sureda-Gibert, Marcela Romero-Reyes, Simon AkermanDiagnostics (Basel, Switzerland)|June 4, 2020
18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the ResultsDavid Moreno-Ajona, Elena Prieto, Fabiana Grisanti, et al.Brain Research|July 29, 2008
Mechanically-induced cortical spreading depression associated regional cerebral blood flow changes are blocked by Na+ ion channel blockadeSimon Akerman, Philip R Holland, Peter J GoadsbyThe Journal of Pharmacology and Experimental Therapeutics|August 7, 2009
Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complexAnnabelle R Charbit, Simon Akerman, Peter J GoadsbyThe Journal of Pharmacology and Experimental Therapeutics|October 5, 2006
Cannabinoid (CB1) receptor activation inhibits trigeminovascular neuronsSimon Akerman, Philip R Holland, Peter J GoadsbyCurrent Opinion in Neurology|February 19, 2010
Dopamine: what's new in migraine?Annabelle R Charbit, Simon Akerman, Peter J GoadsbyCephalalgia : an International Journal of Headache|September 12, 2025
Optimising combined treatment for migraine and temporomandibular disorders (TMDs)Marcela Romero-Reyes, Simon Akerman, Alan M RapoportPageof 21